Parkinson's Disease: <i>Glucocerebrosidase 1</i> Mutation Severity Is Associated with CSF Alpha‐Synuclein Profiles
Stefanie Lerche(German Center for Neurodegenerative Diseases), Kathrin Brockmann(Oregon Health & Science University), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Thomas Gasser(Hertie Institute for Clinical Brain Research), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), Claudia Schulte(School of the Art Institute of Chicago), Ingolf Lachmann, Benjamin Röeben(German Center for Neurodegenerative Diseases), Ann‐Kathrin Hauser(German Center for Neurodegenerative Diseases), Christian Deuschle(German Center for Neurodegenerative Diseases), Benjamin Riebenbauer(German Center for Neurodegenerative Diseases), Isabel Wurster(German Center for Neurodegenerative Diseases), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Katharina Waniek(Leipzig University), Milan Zimmermann(German Center for Neurodegenerative Diseases)
Cited by 61
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k